Furthermore, the combination of GLP-1RAs with other receptor agonists, such as the dual GLP-1glucagon-dependent insulinotropic peptide receptor agonist tirzepatide, is emerging
The combination creates what researchers call a synergistic effectthe two pathways working together produce greater results than either pathway alone
NealBPerkovicVMahaffeyKWde ZeeuwDFulcherGEronduNet al
Because these medications target different physiological systems, combining them addresses multiple metabolic defects simultaneously rather than competing for the same pathway
The solution is suitable for general laboratory use where a sterile, preservative-containing sodium chloride solution is required
They are approved only for type 2 diabetes management and, for specific agents like semaglutide (Wegovy) and liraglutide (Saxenda), chronic weight management in adults with obesity or overweight with comorbidities